** = Publikationen gelistet in SCI/SSCI/Pubmed
** Hallwirth, F; Moser, D; Voortman, M; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, HJ; Fazekas, F; Khalil, M
Immunomodulatory therapy reduces elevated nitric oxide levels in multiple sclerosis patients
EUR J NEUROL. 2018; 25: 254-254.-4th Congress of the European Academy of Neurology (EAN); JUN 16-19, 2018; Lisbon, PORTUGAL.
[Poster]
Web of Science
** Khalil, M; Pirpamer, L; Hofer, E; Voortman, MM; Hallwirth, F; Barro, C; Fazekas, F; Schmidt, R; Kuhle, J
Normative values of serum neurofilament light levels
Multiple Sclerosis Journal, ECTRIMS 2018. 2018; 24(S2):657-658.-34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS); OCT 10-12, 2018; Berlin, GERMANY.
[Poster]
Web of Science
FullText
** Hallwirth, F; Moser, D; Voortman, MM; Greiner, P; Fuchs, S; Enzinger, C; Bachmaier, G; Gruber, H-J; Fazekas; Khalil, M
Serum nitric oxide is increased in untreated multiple sclerosis patients.
Mult Scler J. 2017; 23(S3):586-587.-7th Joint ECTRIMS-ACTRIMS (European-Americas Committee for Treatment and Research of Multiple Sclerosis) Meeting ; OCT 25-28, 2017; Paris, FRANCE.
[Poster]
Web of Science